000 01536 a2200433 4500
005 20250513092939.0
264 0 _c19960905
008 199609s 0 0 eng d
022 _a0022-1899
024 7 _a10.1093/infdis/174.2.387
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWang, J B
245 0 0 _aMucosal antibodies to human cytomegalovirus glycoprotein B occur following both natural infection and immunization with human cytomegalovirus vaccines.
_h[electronic resource]
260 _bThe Journal of infectious diseases
_cAug 1996
300 _a387-92 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAntibodies, Viral
_xanalysis
650 0 4 _aCytomegalovirus Infections
_ximmunology
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunoglobulin Isotypes
_xanalysis
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNasal Mucosa
_ximmunology
650 0 4 _aSaliva
_ximmunology
650 0 4 _aVaccination
650 0 4 _aViral Envelope Proteins
_ximmunology
650 0 4 _aViral Vaccines
_ximmunology
700 1 _aAdler, S P
700 1 _aHempfling, S
700 1 _aBurke, R L
700 1 _aDuliège, A M
700 1 _aStarr, S E
700 1 _aPlotkin, S A
773 0 _tThe Journal of infectious diseases
_gvol. 174
_gno. 2
_gp. 387-92
856 4 0 _uhttps://doi.org/10.1093/infdis/174.2.387
_zAvailable from publisher's website
999 _c8696345
_d8696345